Emerging biomarkers in thyroid practice and research
Simple Summary Tumor biomarkers are molecules at genetic or protein level, or certain
evaluable characteristics. These help in perfecting patient management. Over the past …
evaluable characteristics. These help in perfecting patient management. Over the past …
American Thyroid Association statement on surgical application of molecular profiling for thyroid nodules: current impact on perioperative decision making
Background: Recent advances in research on thyroid carcinogenesis have yielded
applications of diagnostic molecular biomarkers and profiling panels in the management of …
applications of diagnostic molecular biomarkers and profiling panels in the management of …
[图书][B] The Bethesda system for reporting thyroid cytopathology: definitions, criteria, and explanatory notes
SZ Ali, PA VanderLaan - 2023 - books.google.com
The previous edition of The Bethesda System for Reporting Thyroid Cytopathology provided
important updates and advances in the practice of thyroid cytopathology. It was inspired by …
important updates and advances in the practice of thyroid cytopathology. It was inspired by …
Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears
G Lithwick-Yanai, N Dromi, A Shtabsky… - Journal of clinical …, 2017 - jcp.bmj.com
Aims The distinction between benign and malignant thyroid nodules has important
therapeutic implications. Our objective was to develop an assay that could classify …
therapeutic implications. Our objective was to develop an assay that could classify …
MicroRNAs as biomarkers in thyroid carcinoma
M Celano, F Rosignolo, V Maggisano… - … journal of genomics, 2017 - Wiley Online Library
Optimal management of patients with thyroid cancer requires the use of sensitive and
specific biomarkers. For early diagnosis and effective follow‐up, the currently available …
specific biomarkers. For early diagnosis and effective follow‐up, the currently available …
Update on molecular testing for cytologically indeterminate thyroid nodules
M Nishino, M Nikiforova - Archives of pathology & …, 2018 - meridian.allenpress.com
Context.—Approximately 15% to 30% of thyroid nodules that undergo fine-needle aspiration
are classified as cytologically indeterminate, presenting management challenges for …
are classified as cytologically indeterminate, presenting management challenges for …
Deregulation of microRNA expression in thyroid neoplasias
P Pallante, S Battista, GM Pierantoni… - Nature Reviews …, 2014 - nature.com
MicroRNAs (miRNAs) have emerged as a class of powerful gene expression regulators.
Acting at the post-transcriptional level, miRNAs modulate the expression of at least one-third …
Acting at the post-transcriptional level, miRNAs modulate the expression of at least one-third …
Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma
Background: Follicular variant of papillary thyroid carcinoma (FVPTC) shares features of
papillary (PTC) and follicular (FTC) thyroid carcinomas on a clinical, morphological, and …
papillary (PTC) and follicular (FTC) thyroid carcinomas on a clinical, morphological, and …
Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues
Abstract MicroRNA-183 (miR-183) family is proposed as promising biomarkers for early
cancer detection and accurate prognosis as well as targets for more efficient treatment. The …
cancer detection and accurate prognosis as well as targets for more efficient treatment. The …
The role of molecular testing for the indeterminate thyroid FNA
ED Rossi, L Pantanowitz, WC Faquin - Genes, 2019 - mdpi.com
Thyroid nodules are common in the adult population where a majority are benign and only
4.0% to 6.5% are malignant. Fine needle aspiration (FNA) is a key method used in the early …
4.0% to 6.5% are malignant. Fine needle aspiration (FNA) is a key method used in the early …